Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

October’s top stories: New cancer drug delivery approach, J&J Ebola trial

UK researchers develop a new method to improve drug delivery in cancer treatment, J&J initiates clinical trial of Janssen's Ebola prime-boost vaccine regimen in Sierra Leone and Bayer begins Phase III trial of riociguat to treat children with PAH. Drugdevelopment-technology.com wraps up key headlines from October.

Go Top